ENTO
Entero Therapeutics Inc

3,077
Mkt Cap
$13.18M
Volume
32,633.00
52W High
$5.84
52W Low
$0.9693
PE Ratio
-0.39
ENTO Fundamentals
Price
$3.56
Prev Close
$3.92
Open
$3.61
50D MA
$3.33
Beta
-0.22
Avg. Volume
98,109.59
EPS (Annual)
-$15.98
P/B
0.44
Rev/Employee
$0.00
Loading...
Loading...
GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2

Frequently Asked Questions

What is Market Cap of GridAI Technologies Corp.?
What is the 52-week high for GridAI Technologies Corp.?
What is the 52-week low for GridAI Technologies Corp.?
What is GridAI Technologies Corp. stock price today?
What was GridAI Technologies Corp. stock price yesterday?
What is the PE ratio of GridAI Technologies Corp.?
What is the Price-to-Book ratio of GridAI Technologies Corp.?
What is the 50-day moving average of GridAI Technologies Corp.?
How many employess does GridAI Technologies Corp. has?

Latest ENTO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.